Developer docs
API playgroundTry for free, no card

Search company profiles

Strateos

Full company profile

uuid0000f3h

Namestring
Strateos
Legal namestring
Strateos, Inc.
Websiteurl
strateos.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Strateos automates chemistry, biology, and tissue analysis into closed-loop robotic labs that accelerate drug discovery programs. Through a combination of best-in-class robotics and control systems, advanced software for imaging and analytics, and remote cloud laboratories, they enable pharmaceutical partners to more rapidly and efficiently discover new drug candidates. Born of a merger between Transcriptic and 3Scan, Strateos combines the strengths of those companies to amplify their impact and accelerate drug discovery. Transcriptic developed the first robotic cloud laboratory platform for on-demand life science research, which is currently in use at several top pharmaceutical and biotechnology companies. 3Scan combined automation, machine learning and computer vision to extract spatial data from tissue samples and create detailed 3D representations as well as quantitative analysis of complex anatomical structures. Now these two portfolios will be combined to offer a suite of technologies for accelerating drug discovery and early development. By expressing life science methods as data, infrastructure virtualization will become possible. "Science-as-a-Service" will power the next generation of discovery, driven by huge efficiencies of both time and money. Transcriptic was founded in 2012 to create a better way to get lab work done. Tired of spending endless hours at the bench pretending to be slow, error-prone robots, they set out to build a modern solution to the day-to-day process of wet lab biology. Drawing on deep computer science and electrical engineering backgrounds in addition to life science, Strateos was born: a meticulously optimized, technology-enabled remote lab. Using state-of-the-art automation and control technology, and an emphasis on user experience and usability, they are working on building a stark contrast to the long, complicated sales process, high prices, and slow turnarounds of traditional CROs. They are working hard to build a great company that can be a true partner for your lab for a long time, progressively enabling ever greater levels of productivity and efficiency. They are scientists building for scientists.

Short descriptiontext

Strateos is a SaaS-based biotechnology company that provides robotic solutions for biology labs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMenlo Park, United States
HQ citystring
Menlo Park
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cloud lab automation, drug discovery services, high throughput screening, lab robotics platform, biotech SaaS solutions
Industry4 codes
PRIMARYHLAGAJAG
Lab Automation, Instrument Control & Workflow Orchestration Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAIAD
Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations)
SECONDARYHLACAMAI
Lab Middleware, Instrument Connectivity & Automation
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • Services-Prepackaged Software7372
Product category
Cloud Lab Automation Software
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Cloud Lab Automation Services
TypeSubscription Recurring
Description

Subscription and usage-based access to remote-controlled robotic cloud labs. Scientists pay for experiment execution, automation module access, and data generation services. Pricing based on protocol complexity, number of runs, and throughput requirements.

strateos.com
2Lab Control Software Licensing
TypeSubscription Recurring
Description

Enterprise software licensing for organizations to deploy Strateos Lab Control Software in their own facilities. Includes Protocol Request, Request Management, Data Acquisition, and Sample Tracking modules.

strateos.com
3Professional Services
TypeProfessional Services
Description

Custom assay development, project strategy guidance, implementation support, and training services for cloud lab and software deployments.

strateos.com
4Smart Lab Design & Build Services
TypeProfessional Services
Description

Consulting and implementation services for organizations building their own automated labs. Includes facility design, workcell integration, and software deployment.

strateos.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales
Pricing details3 tiers
1Cloud Lab Access - Control Our Lab
ModelSubscriptionBilling cadenceAnnual
Notes

On-demand access to Strateos cloud labs for experiment execution. Pricing varies by protocol complexity, number of automation runs, and experiment throughput. Annual contracts with volume commitments likely available for enterprise clients.

strateos.com
2Lab Control Software - Control Your Lab
ModelSubscriptionBilling cadenceAnnual
Notes

Software licensing for organizations deploying Strateos lab control software in their own facilities. Enterprise licensing with modular pricing based on features and scale.

strateos.com
3Design & Build Services - Build Your Lab
ModelOtherBilling cadenceMulti-year contract
Notes

Custom consulting and implementation services for building automated lab facilities. Pricing project-based and scope-dependent.

strateos.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1SmartLab Platform
Description

Cloud Lab Automation-as-a-Service Platform for remote scientific experimentation

strateos.com
+2 more records
Core offering1 text field

Strateos operates the industry's first Cloud Lab Automation-as-a-Service Platform, providing remote-controlled robotic laboratories and proprietary lab control software. Through three delivery modes — Control Our Lab (remote access to Strateos-operated cloud labs in Menlo Park and San Diego), Control Your Lab (lab control software licensing for customer facilities), and Build Your Lab (custom automated lab design-build services) — the company enables scientists to design, run, and analyze scientific experiments remotely via web browser or API, supporting high-throughput screening, automated DMTA cycles, antibody discovery, and small molecule drug discovery workflows.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 70% reduction in DMTA cycle time - 14 analog compounds completed in ~40 hours over 4 days versus 2 weeks for conventional CRO
+4 more records
Product overview1 text field

Strateos offers a Cloud Lab Automation-as-a-Service Platform as its core product, with three main access modes: Control Our Lab (remote access to Strateos's robotic cloud labs), Control Your Lab (lab control software for organizations' own facilities), and Build Your Lab (design-build services for creating private automated facilities). The platform integrates specialized modules including AI for Drug Discovery, Antibody Discovery, Discovery Biology, and Small Molecule Drug Discovery (covering assay development, hit identification, hit-to-lead, lead optimization, medicinal chemistry, chemical libraries, synthetic biology, tissue technology, high content imaging, and automated DMTA cycles). The architecture combines high-throughput robotics, remote web browser access, secure APIs, and closed-loop automation to accelerate scientific discovery across pharma, biotech, startups, academia, and CROs.

Product and service14 records
1Strateos Cloud Lab Automation-as-a-Service Platform
CategoryCloud Lab Automation Platform
Description

Industry-first Cloud Lab Automation-as-a-Service Platform that lets scientists worldwide design, run, and analyze experiments remotely via web browser using Strateos's robotic laboratories; combines high-throughput lab automation with proprietary control software for pharmaceutical, biotech, academic, and AI-first customers.

2Control Our Lab
CategoryRemote Cloud Lab Access
Description

On-demand remote access to Strateos's robotic cloud labs in Menlo Park and San Diego; scientists orchestrate workflows virtually and command lab automation modules from anywhere in the world.

3Control Your Lab (Lab Control Software)
CategoryLab Automation Software
Description

Lab automation software that lets organizations control their own scientific instruments and laboratories locally and worldwide, schedule workflows, and manage scientific data; includes Protocol Request, Request Management, Data Acquisition, and Sample Tracking modules.

4Build Your Lab (Design & Build Services)
CategoryLab Design-Build Services
Description

Smart lab facility design-build services and lab control software that enable organizations to create their own automated facilities, including modular workcells and smart facility design, with the option to toggle between private labs and Strateos's remote-controlled robotic cloud labs.

5AI for Drug Discovery
CategoryDrug Discovery Services
Description

AI-powered drug discovery platform combining best-in-class robotics and control systems with advanced software for imaging and analytics to help pharmaceutical partners more rapidly discover new drug candidates.

6Antibody Discovery
CategoryDrug Discovery Services
Description

Automated antibody discovery workflows using optimized automation workcells, including molecular biology gene assembly (Golden Gate, NEBuilder), high-throughput screening, characterization, and validation via MSD multi-array technology and ELISA-based assays.

7Discovery Biology
CategoryDrug Discovery Services
Description

Integrative discovery biology services connecting remote R&D teams to Strateos's smart labs for on-demand access to molecular biology, protein expression, screening assays, and analytical workflows.

8Small Molecule Drug Discovery
CategoryDrug Discovery Services
Description

Integrated small molecule screening and drug discovery workflows encompassing assay development, hit identification, hit-to-lead, lead optimization, and automated medicinal chemistry for small molecule therapeutics.

9Chemical Libraries (500K and 50K)
CategoryScreening Reagents
Description

Diverse library of 500K ready-to-use compounds for high throughput screening, with a 50K diversity set; compounds filtered by Lipinski Rule of 5 and stored on-site at the San Diego facility for immediate use.

10Assay Onboarding and Development
CategoryDrug Discovery Services
Description

Custom development of biochemical, biophysical, and cell-based assays using industry-standard and innovative technologies, supporting target classes including GPCRs, kinases, ion channels, nuclear receptors, proteases, and protein-protein interactions.

11Hit Identification (High Throughput Screening)
CategoryDrug Discovery Services
Description

State-of-the-art fully automated robotic platform for biochemical, phenotypic, and cellular HTS assays in 384- or 1536-well formats, capable of screening up to 100,000 compounds per day.

12Hit-to-Lead and Lead Optimization
CategoryDrug Discovery Services
Description

Service that selects promising hits and leverages automated chemical synthesis workflows for faster experimental screening cycles, decreasing duration and hands-on time to reduce overall drug discovery timeline.

13Medicinal Chemistry
CategoryDrug Discovery Services
Description

Extensive medicinal chemistry capabilities including chemical synthesis, purification, and analysis via robotics and automation; reproducible and validated reactions using Buchwald, amide, and Suzuki reactions at 0.7 mmol scale.

14Synthetic Biology / Biofoundry
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1University of Washington
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Academic research partnership where Strateos provides lab automation and robotics capabilities while researchers focus on AI-based protein design. Professor Philip Romero cited the partnership as enabling focus on computational work while leveraging Strateos automation expertise.

strateos.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Emerald Cloud Lab
TypeDirect peer
Description

Emerald Cloud Lab operates remote, robotic cloud laboratories that scientists can access via the web to run experiments on demand. It is the closest direct competitor to Strateos's 'Control Our Lab' offering, with similar positioning around fully automated, remotely orchestrated wet-lab workflows.

2Benchling
TypeDirect peer
Description

Benchling is a cloud-based R&D platform providing ELN, LIMS, and molecular biology workflow software widely used across biopharma. It is a direct peer in the life-science software stack that Strateos integrates with, and increasingly overlaps in laboratory data management and workflow orchestration.

3Tecan
TypeBroad incumbent
Description

Tecan is a leading manufacturer of laboratory automation instruments, liquid handling robotics, and workstations used in drug discovery and diagnostics. It represents the incumbent hardware layer that Strateos's cloud orchestration sits on top of, and a potential competitor if Tecan expands into software/cloud layers.

4Hamilton Company
TypeBroad incumbent
Description

Hamilton Robotics provides automated liquid handling workstations and lab robotic systems widely used in high-throughput screening. Comparable as an incumbent lab-automation vendor whose installed base Strateos both competes with and depends on as a hardware substrate.

5Thermo Fisher Scientific
TypeBroad incumbent
Description

Thermo Fisher is a global life-sciences tools and instrumentation incumbent spanning instruments, consumables, software (including LIMS/ELN), and CRO services. It is a broad incumbent whose instruments Strateos integrates (e.g., KingFisher Flex) and whose scale and breadth could pressure Strateos in either direction.

6Ginkgo Bioworks
TypeEmerging player
Description

Ginkgo Bioworks operates a large-scale synthetic biology platform (its 'Foundry') combining robotics and automation for cell engineering. It overlaps with Strateos's synthetic biology and biofoundry offerings, particularly for AI-driven organism engineering customers.

7LabVantage Solutions
TypeDirect peer
Description

LabVantage provides LIMS and laboratory informatics software for regulated and research labs across pharma and biotech. Comparable as a peer in lab data management and instrument connectivity, areas where Strateos's 'Lab Control Software' competes or integrates.

8Arctoris
TypeDirect peer
Description

Arctoris offers automated, remotely operated biology experimentation as a service for drug discovery, including biochemical and cell-based assays. A direct peer in the cloud-delivered wet-lab experimentation category that competes for similar biotech and pharma discovery budgets.

9Automata Labs
TypeEmerging player
Description

Automata (and its open automation platform) builds integrated lab automation hardware and software for life-science workflows, with an emphasis on benchtop automation. It overlaps with Strateos on modular automation workcells and cloud-orchestrated lab workflows.

10PerkinElmer
TypeBroad incumbent
Description

PerkinElmer provides life-sciences instrumentation, software (including the Signals Notebook ELN integrated with Strateos), and diagnostic solutions. It is both an integration partner and a broad incumbent that competes for informatics and lab automation budgets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors28 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Strateos

Cloud Lab Automation Softwarestrateos.com

Strateos is a SaaS-based biotechnology company that provides robotic solutions for biology labs.

What Strateos does

Strateos automates chemistry, biology, and tissue analysis into closed-loop robotic labs that accelerate drug discovery programs. Through a combination of best-in-class robotics and control systems, advanced software for imaging and analytics, and remote cloud laboratories, they enable pharmaceutical partners to more rapidly and efficiently discover new drug candidates. Born of a merger between Transcriptic and 3Scan, Strateos combines the strengths of those companies to amplify their impact and accelerate drug discovery. Transcriptic developed the first robotic cloud laboratory platform for on-demand life science research, which is currently in use at several top pharmaceutical and biotechnology companies. 3Scan combined automation, machine learning and computer vision to extract spatial data from tissue samples and create detailed 3D representations as well as quantitative analysis of complex anatomical structures. Now these two portfolios will be combined to offer a suite of technologies for accelerating drug discovery and early development. By expressing life science methods as data, infrastructure virtualization will become possible. "Science-as-a-Service" will power the next generation of discovery, driven by huge efficiencies of both time and money. Transcriptic was founded in 2012 to create a better way to get lab work done. Tired of spending endless hours at the bench pretending to be slow, error-prone robots, they set out to build a modern solution to the day-to-day process of wet lab biology. Drawing on deep computer science and electrical engineering backgrounds in addition to life science, Strateos was born: a meticulously optimized, technology-enabled remote lab. Using state-of-the-art automation and control technology, and an emphasis on user experience and usability, they are working on building a stark contrast to the long, complicated sales process, high prices, and slow turnarounds of traditional CROs. They are working hard to build a great company that can be a true partner for your lab for a long time, progressively enabling ever greater levels of productivity and efficiency. They are scientists building for scientists.

Strateos firmographics

Firmographics
Name
Strateos
Legal name
Strateos, Inc.
Website
https://strateos.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
Strateos is a SaaS-based biotechnology company that provides robotic solutions for biology labs.
Ownership category
akta.pro rank

Strateos industry classification

Industry
Product category
Cloud Lab Automation Software
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Computer Systems Design and Related Services (54151)
SIC
Laboratory Analytical Instruments (3826), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAG
Lab Automation, Instrument Control & Workflow Orchestration Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAIAD
Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations)
SECONDARYHLACAMAI
Lab Middleware, Instrument Connectivity & Automation
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Cloud lab automation
  • Drug discovery services
  • High throughput screening
  • Lab robotics platform
  • Biotech SaaS solutions

Where Strateos is headquartered

Location

Headquarters

HQ city
Menlo Park
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Strateos business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Revenue model

  1. Cloud Lab Automation Services: Subscription and usage-based access to remote-controlled robotic cloud labs. Scientists pay for experiment execution, automation module access, and data generation services. Pricing based on protocol complexity, number of runs, and throughput requirements.
  2. Lab Control Software Licensing: Enterprise software licensing for organizations to deploy Strateos Lab Control Software in their own facilities. Includes Protocol Request, Request Management, Data Acquisition, and Sample Tracking modules.
  3. Professional Services: Custom assay development, project strategy guidance, implementation support, and training services for cloud lab and software deployments.
  4. Smart Lab Design & Build Services: Consulting and implementation services for organizations building their own automated labs. Includes facility design, workcell integration, and software deployment.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualCloud Lab Access - Control Our Lab
SubscriptionAnnualLab Control Software - Control Your Lab
OtherMulti-year contractDesign & Build Services - Build Your Lab

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Strateos product offering

Product offering

Core offering

Strateos operates the industry's first Cloud Lab Automation-as-a-Service Platform, providing remote-controlled robotic laboratories and proprietary lab control software. Through three delivery modes — Control Our Lab (remote access to Strateos-operated cloud labs in Menlo Park and San Diego), Control Your Lab (lab control software licensing for customer facilities), and Build Your Lab (custom automated lab design-build services) — the company enables scientists to design, run, and analyze scientific experiments remotely via web browser or API, supporting high-throughput screening, automated DMTA cycles, antibody discovery, and small molecule drug discovery workflows.

Product overview

Strateos offers a Cloud Lab Automation-as-a-Service Platform as its core product, with three main access modes: Control Our Lab (remote access to Strateos's robotic cloud labs), Control Your Lab (lab control software for organizations' own facilities), and Build Your Lab (design-build services for creating private automated facilities). The platform integrates specialized modules including AI for Drug Discovery, Antibody Discovery, Discovery Biology, and Small Molecule Drug Discovery (covering assay development, hit identification, hit-to-lead, lead optimization, medicinal chemistry, chemical libraries, synthetic biology, tissue technology, high content imaging, and automated DMTA cycles). The architecture combines high-throughput robotics, remote web browser access, secure APIs, and closed-loop automation to accelerate scientific discovery across pharma, biotech, startups, academia, and CROs.

Differentiator

Problem solved

Functional benefit

Brands

  • SmartLab Platform: Cloud Lab Automation-as-a-Service Platform for remote scientific experimentation
  • Strateos Lab Control Software
  • SmartLab Studio

Products and services

  • Strateos Cloud Lab Automation-as-a-Service Platform Industry-first Cloud Lab Automation-as-a-Service Platform that lets scientists worldwide design, run, and analyze experiments remotely via web browser using Strateos's robotic laboratories; combines high-throughput lab automation with proprietary control software for pharmaceutical, biotech, academic, and AI-first customers.
  • Control Our Lab On-demand remote access to Strateos's robotic cloud labs in Menlo Park and San Diego; scientists orchestrate workflows virtually and command lab automation modules from anywhere in the world.
  • Control Your Lab (Lab Control Software) Lab automation software that lets organizations control their own scientific instruments and laboratories locally and worldwide, schedule workflows, and manage scientific data; includes Protocol Request, Request Management, Data Acquisition, and Sample Tracking modules.
  • Build Your Lab (Design & Build Services) Smart lab facility design-build services and lab control software that enable organizations to create their own automated facilities, including modular workcells and smart facility design, with the option to toggle between private labs and Strateos's remote-controlled robotic cloud labs.
  • AI for Drug Discovery AI-powered drug discovery platform combining best-in-class robotics and control systems with advanced software for imaging and analytics to help pharmaceutical partners more rapidly discover new drug candidates.
  • Antibody Discovery Automated antibody discovery workflows using optimized automation workcells, including molecular biology gene assembly (Golden Gate, NEBuilder), high-throughput screening, characterization, and validation via MSD multi-array technology and ELISA-based assays.
  • Discovery Biology Integrative discovery biology services connecting remote R&D teams to Strateos's smart labs for on-demand access to molecular biology, protein expression, screening assays, and analytical workflows.
  • Small Molecule Drug Discovery Integrated small molecule screening and drug discovery workflows encompassing assay development, hit identification, hit-to-lead, lead optimization, and automated medicinal chemistry for small molecule therapeutics.
  • Chemical Libraries (500K and 50K) Diverse library of 500K ready-to-use compounds for high throughput screening, with a 50K diversity set; compounds filtered by Lipinski Rule of 5 and stored on-site at the San Diego facility for immediate use.
  • Assay Onboarding and Development Custom development of biochemical, biophysical, and cell-based assays using industry-standard and innovative technologies, supporting target classes including GPCRs, kinases, ion channels, nuclear receptors, proteases, and protein-protein interactions.
  • Hit Identification (High Throughput Screening) State-of-the-art fully automated robotic platform for biochemical, phenotypic, and cellular HTS assays in 384- or 1536-well formats, capable of screening up to 100,000 compounds per day.
  • Hit-to-Lead and Lead Optimization Service that selects promising hits and leverages automated chemical synthesis workflows for faster experimental screening cycles, decreasing duration and hands-on time to reduce overall drug discovery timeline.
  • Medicinal Chemistry Extensive medicinal chemistry capabilities including chemical synthesis, purification, and analysis via robotics and automation; reproducible and validated reactions using Buchwald, amide, and Suzuki reactions at 0.7 mmol scale.
  • Synthetic Biology / Biofoundry

Quantifiable outcome

  • 70% reduction in DMTA cycle time - 14 analog compounds completed in ~40 hours over 4 days versus 2 weeks for conventional CRO
  • +4 more outcomes

Companies that use Strateos

Customer profile

Named customers5 records

Segments6 records

Ideal customer profiles4 records

Strateos technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability8 records

Feature8 records

Strateos partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • University of WashingtonstrategicStrategic or Co-development PartnerAcademic research partnership where Strateos provides lab automation and robotics capabilities while researchers focus on AI-based protein design. Professor Philip Romero cited the partnership as enabling focus on computational work while leveraging Strateos automation expertise.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Strateos competitors and assessment

Company assessment

Direct peers

  • Emerald Cloud Lab: Emerald Cloud Lab operates remote, robotic cloud laboratories that scientists can access via the web to run experiments on demand. It is the closest direct competitor to Strateos's 'Control Our Lab' offering, with similar positioning around fully automated, remotely orchestrated wet-lab workflows.
  • Benchling: Benchling is a cloud-based R&D platform providing ELN, LIMS, and molecular biology workflow software widely used across biopharma. It is a direct peer in the life-science software stack that Strateos integrates with, and increasingly overlaps in laboratory data management and workflow orchestration.
  • LabVantage Solutions: LabVantage provides LIMS and laboratory informatics software for regulated and research labs across pharma and biotech. Comparable as a peer in lab data management and instrument connectivity, areas where Strateos's 'Lab Control Software' competes or integrates.
  • Arctoris: Arctoris offers automated, remotely operated biology experimentation as a service for drug discovery, including biochemical and cell-based assays. A direct peer in the cloud-delivered wet-lab experimentation category that competes for similar biotech and pharma discovery budgets.

Broad incumbents

  • Tecan: Tecan is a leading manufacturer of laboratory automation instruments, liquid handling robotics, and workstations used in drug discovery and diagnostics. It represents the incumbent hardware layer that Strateos's cloud orchestration sits on top of, and a potential competitor if Tecan expands into software/cloud layers.
  • Hamilton Company: Hamilton Robotics provides automated liquid handling workstations and lab robotic systems widely used in high-throughput screening. Comparable as an incumbent lab-automation vendor whose installed base Strateos both competes with and depends on as a hardware substrate.
  • Thermo Fisher Scientific: Thermo Fisher is a global life-sciences tools and instrumentation incumbent spanning instruments, consumables, software (including LIMS/ELN), and CRO services. It is a broad incumbent whose instruments Strateos integrates (e.g., KingFisher Flex) and whose scale and breadth could pressure Strateos in either direction.
  • PerkinElmer: PerkinElmer provides life-sciences instrumentation, software (including the Signals Notebook ELN integrated with Strateos), and diagnostic solutions. It is both an integration partner and a broad incumbent that competes for informatics and lab automation budgets.

Emerging players

  • Ginkgo Bioworks: Ginkgo Bioworks operates a large-scale synthetic biology platform (its 'Foundry') combining robotics and automation for cell engineering. It overlaps with Strateos's synthetic biology and biofoundry offerings, particularly for AI-driven organism engineering customers.
  • Automata Labs: Automata (and its open automation platform) builds integrated lab automation hardware and software for life-science workflows, with an emphasis on benchtop automation. It overlaps with Strateos on modular automation workcells and cloud-orchestrated lab workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Strateos social profiles

Digital presence

Strateos financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Strateos leadership team

Management profile

Number of profiles

Profiles7 records

Strateos funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors28 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Strateos M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Strateos

What does Strateos do?

Strateos operates the industry's first Cloud Lab Automation-as-a-Service Platform, providing remote-controlled robotic laboratories and proprietary lab control software. Through three delivery modes — Control Our Lab (remote access to Strateos-operated cloud labs in Menlo Park and San Diego), Control Your Lab (lab control software licensing for customer facilities), and Build Your Lab (custom automated lab design-build services) — the company enables scientists to design, run, and analyze scientific experiments remotely via web browser or API, supporting high-throughput screening, automated DMTA cycles, antibody discovery, and small molecule drug discovery workflows.

Is Strateos a public or private company?

Strateos is a private company. It is classified as venture growth investor backed and is currently operating.

When was Strateos founded?

Strateos was founded in 2012. It employs 11 to 50 people.

Where is Strateos based?

Strateos is headquartered in Menlo Park, United States, in the North America region.

How does Strateos make money?

Four revenue lines are on record. Cloud Lab Automation Services are the primary driver. The others are lab Control Software Licensing, professional Services and smart Lab Design & Build Services.

Who are Strateos's main competitors?

Direct peers on record are Emerald Cloud Lab, Benchling, LabVantage Solutions and Arctoris. Broad incumbents are Tecan, Hamilton Company, Thermo Fisher Scientific and PerkinElmer. Emerging players are Ginkgo Bioworks and Automata Labs.

Does Strateos have an API?

Yes. Strateos provides secure APIs for programmatic integration into clients' existing data engineering pipelines, software systems, and data analysis tools. The platform enables scientists to orchestrate scientific workflows virtually and interactively command and control lab automation modules programmatically. Scientists can clearly define protocol design parameters and request run submissions for new experiments, as well as view and manage all existing experiments through the API. The API supports integration with third-party ELNs and LIMS systems. Developer documentation is at developers.strateos.com/docs.

What industry is Strateos in?

Strateos's product category is Cloud Lab Automation Software. Its primary akta.pro industry code is HLAGAJAG, Lab Automation, Instrument Control & Workflow Orchestration Software, with a secondary code of HLAGAIAD, Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
RdworldonlineIs your lab up next for automation?Self-driving laboratories (SDLs) that use AI, robotics, and advanced computing to autonomously design and conduct experiments are emerging globally, with companies like Emerald Cloud Lab, Intrepid, Strateos, Merck KGaA, Unilever, and Insilico Medicine implementing these technologies alongside academic institutions such as Carnegie Mellon University and the University of Toronto. These autonomous labs report benefits including reduced human error, 24/7 operation, accelerated turnaround from months to days, and potential cost reductions, with McKinsey estimating automation in pharma could cut development costs by 25% and bring medicines to market 500 days faster. While AI will augment rather than replace scientists, SDLs remain largely aspirational, requiring substantial human oversight due to challenges including AI hallucinations, limited context windows, and safety restrictions that prevent fully autonomous operation.AxiosAI copilots and cloud labs turbocharge researchAI lab copilots and cloud labs are accelerating drug and material research by automating experiments. Strateos reports cutting protein engineering cycles from 8 days to 6 hours, and Emerald Cloud Lab plans to open a remote-controlled university lab in early 2024. Proponents aim to compress uncertainty and expand access to equipment.BioSpaceStrateos Appoints Alexander K. Arrow as Chief Financial Officer and Expands TeamStrateos appointed Alexander K. Arrow as Chief Financial Officer and Juliet M. Moritz as Vice President of Project Management Office. Arrow brings 27 years of experience from Carlsmed and other roles, while Moritz will oversee customer deployments of the LodeStar software platform.GlobeNewswireWorld’s First & Only Cloud Lab, HTE, & Lab Automation Virtual Conference20/15 Visioneers will host its second annual virtual conference on cloud labs, high-throughput experimentation, and lab automation from November 8-10, 2022. The event features keynote speakers and industry presentations, with Strateos as top sponsor and free registration for attendees and non-vendor speakers.TecHRStrateos Expands Leadership Team to Meet Increasing Customer Demand for Its Remote Access Laboratories and Lab Automation SoftwareStrateos appointed Jason Pontin as chairman of its board, and named David Lynch chief business officer and Allison Herd vice president of people. The company also added Jeff Finer as an independent board member. The appointments aim to support Strateos's remote access laboratory and lab automation software business.VC News DailyStrateos Gains $56.1M Series BStrateos, a life science technology company based in Menlo Park, California, has raised $56.1 million in Series B funding. The round was led by DCVC and Lux Capital, with participation from Eli Lilly and Company, Ally Bridge Group, Black Diamond Ventures, Mack & Co. LLC, and Castor Ventures. The company plans to use the funds to advance its mission of combining data, computation, automation, and high-throughput robotics to accelerate scientific discovery in life sciences.FinSMEsStrateos Raises $56.1M in Series B FundingStrateos, a Menlo Park-based developer of remote access laboratories and lab control software, raised $56.1 million in Series B funding led by DCVC and Lux Capital. The company plans to utilize the capital to further develop its SmartLab Platform solutions for pharmaceutical and synthetic biology research. Participation in the round included new investors such as Eli Lilly and Company and Ally Bridge Group.ZapierStrateos Closes $56 Million Series B Financing to Accelerate the Roll-Out of its SmartLab of the Future PlatformStrateos announced the closing of a $56.1 million Series B financing round led by DCVC and Lux Capital, with participation from investors including Eli Lilly and Company. The company plans to use these funds to expand its SmartLab Platform, which integrates AI-enabled automation and remote-access laboratory capabilities for life sciences research. This investment supports the acceleration of pharmaceutical and synthetic biology R&D through decentralized discovery.ForbesRemote-Controlled Labs? Strateos Raises $56 Million To Build Out Its Vision Of Scientific AutomationStrateos raised $56 million in funding led by DCVC and Lux Capital to expand its network of remote-controlled, automated laboratories for life sciences research. The company, which has reached a valuation of approximately $200 million, operates facilities such as its San Diego lab developed in partnership with Eli Lilly to accelerate drug discovery.FierceBiotechStrateos scores $56M to smarten up its SmartLab platform for robotic, remote R&DStrateos has closed a $56.1 million Series B funding round to expand its SmartLab platform, which enables remote robotic research and development for life sciences. The capital will be used to add new R&D tools and accelerate the deployment of automated lab capabilities to biotech and pharma scientists. Eli Lilly participated in the funding, building on an existing partnership that includes the Lilly Life Sciences Studio.